About Robert Kniaz
Form D filings for Preply from 2021 to 2023 list Robert Kniaz as director.
Form D filings also name Robert Kniaz as a director at Aviceda Therapeutics.
Robert Kniaz first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Kniaz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Kniaz works with at each company, as listed on that company's latest Form D.
Preply, Inc. · Form D, Jun 30, 2023
MG
Mariusz Gralewski
Director
KB
Kyrylo Bigay
President and director
VP
Victor Patterson
Director
DB
Dmytro Boroday
Director
DV
Dmytro Voloshyn
Director
Aviceda Therapeutics, Inc. · Form D, Mar 28, 2022
DV
Dmytro Voloshyn
Director
RD
Ross Darwin
Director
MG
Mariusz Gralewski
Director
KB
Kyrylo Bigay
President and director